Tiny Gem

Lidar Pioneer Cepton, Inc. (NASDAQ: CPTN) Bridges Technological Gaps to Advance Mass Market ADAS Adoption

  • Cepton unveiled its Vista(R)-X120 Plus earlier this year at CES 2023, one of the largest tech tradeshows this year, where it was named a CES 2023 innovation award honoree for next-generation lidar products
  • Vista(R)-X120 Plus features a wider field of view, software-definable regions of interest, and faster data transmission with a target price below $500, enabling high-volume production and faster mass-market adoption
  • Vista(R)-X120 Plus is smaller and lighter, allowing for seamless integration without significantly affecting vehicle design
  • Cepton collaborates with many global OEMS, and recently won the largest commercial lidar deployment contract in the tolling sector to date

Advanced Driver Assistance Systems (“ADAS”) make roads safer by using sensors, cameras, and other technology to control speed, monitor blind spots, prevent collisions, and automate emergency braking. While the technology has advanced rapidly in recent years, some challenges remain, including data integration from multiple systems, information processing power and speed, and sensor reliability and accuracy.

Cepton’s (NASDAQ: CPTN) latest automotive-grade lidar solution — the Vista(R)-X120 Plus — addresses those challenges and features improvements that set new standards for perception technology.

Integrated ADAS sensors must accurately and reliably detect objects in all weather and lighting conditions, and discern which objects are most important when making decisions. What makes Cepton’s lidar technology stand out is its ability to see things on the road that the driver may not. Even in low light conditions, Cepton’s lidar becomes an asset to driver safety. For example, the latest Vista Plus model bridges those critical technological gaps with a 30-degree wider field-of-view and a software-definable region of interest (“ROI”) that rotates the sensor 360 degrees to capture higher levels of environmental detail. Furthermore, the Vista(R)-X120 Plus transmits data 500% faster, enabling the system to quickly detect, analyze, and respond to the movement of vehicles, pedestrians, animals, and other moving objects.

The Vista(R)-X120 also offers a 50% reduction in height and a 20% reduction in overall size, allowing manufacturers to seamlessly integrate the technology without significantly affecting the vehicle’s design. In addition, the model’s target cost for high-volume production is below $500, enabling mass-market deployment for a larger range of vehicles at varying price points.

CPTN engages with all top 10 global automotive OEMs and collaborates with numerous worldwide partners to develop lidar solutions for an extensive range of applications. These include early-warning intrusion detection systems, crowd analytics solutions, free-flow e-tolling, and lidar technology for smart transportation infrastructure. Most recently, the company secured the largest commercial lidar deployment contract in the tolling sector to date, which involves the deployment of Cepton’s Sora series sensors on several major tollways in the Tri-State area and Northern California (https://ibn.fm/sBKyI).

“We’re proud to announce our new contract win with one of the largest tolling system operators in the U.S. and contribute to the infrastructure rebuilding initiative,” said Dr. Jun Pei, Co-founder, and CEO of Cepton. “In addition to superior performance, our Sora lidars were designed using the same auto-grade building blocks that have been validated by OEMs through our flagship automotive lidar program, and are reliable, embeddable, scalable, and energy efficient, which are key advantages for tolling applications.”

Founded in 2016, Cepton commercializes high-performance, high-quality lidar solutions through engagements with multiple global partners, including all top 10 global automotive OEMs. The company is headquartered in San Jose, California, with a center of excellence facility in Troy, Michigan.

For more information, visit the company’s website at www.Cepton.com

NOTE TO INVESTORS: The latest news and updates relating to CPTN are available in the company’s newsroom at https://ibn.fm/CPTN

About TinyGems

TinyGems is your guide to the best and brightest in the under-appreciated small-cap sector. As one of 50+ brands within the InvestorBrandNetwork (“IBN”), TinyGems provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to reach millions of social media followers; and (5) a full array of corporate communications solutions. It’s time to uncover some of the best-kept secrets on Wall Street. TinyGems features innovative small-cap companies with huge potential, putting a spotlight on the best and brightest of these disruptors that have the technology, the talent, the drive, and the business models to make a huge impact in the markets and in portfolios. Whether it’s a game changing technology, a new more profitable product or service, or a star in a hot sector, TinyGems is the go-to source for actionable intelligence.

To receive SMS text alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, California
www.TinyGems.com
310.299.1717 Office
Editor@TinyGems.com

TinyGems is part of the InvestorBrandNetwork

Christian Amiscua

Share
Published by
Christian Amiscua

Recent Posts

New Molecule May Open New Therapeutic Pathway Against Brain Cancer

Researchers at Brown University Health have identified a molecule that could potentially alter how glioblastoma…

21 hours ago

Early Trial Suggests mRNA Vaccine Could Be Effective Against Pancreatic Cancer 

A personalized mRNA vaccine has shown signs of meaningfully extending survival in pancreatic cancer patients. Six-year…

6 days ago

Encryption Codes at Risk as Quantum Computing Advances

Most digital communications are secured by encryption built on mathematical problems so hard that conventional…

1 week ago

Precision Oncology Is Shifting Toward Combination Strategies, Ultimately Changing How New Therapies Are Built

Targeted cancer therapies are increasingly being paired with immunotherapy and chemotherapy to improve outcomes across…

2 weeks ago

Frontieras North America Inc. Launches New Era for Full Coal Utilization

Frontieras notes milestone moment: groundbreaking of facility based on a new industrial model built on…

2 weeks ago

Scientists Discover Brain Cells That Aid Brain Cancer Development

Canadian scientists have made an unexpected finding about glioblastoma, one of the deadliest and hardest-to-treat forms of brain cancer.…

2 weeks ago